Partial-accelerated irradiation with stereotactic radiotherapy at a dose of 30 Gy in 5 fractions in early breast cancer
ConclusionAPBI with SBRT 30 Gy in 5 fractions in early-stage breast cancer is a feasible technique, very-well tolerated and has excellent oncologic and cosmetic outcome during our follow-up period.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chronic Pain | External Beam Therapy | Neurology | Neurosurgery | Pain | Toxicology